CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key market segments

1.2.1.List of key players profiled in the report

1.3.Research methodology

1.3.1.Primary research
1.3.2.Secondary research
1.3.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Top player positioning

3.2.1.Top investment pockets
3.2.2.Top winning strategies, 2019

3.3.Key forces shaping clinical trial imaging services industry/Market
3.4.Market dynamics

3.4.1.Drivers

3.4.1.1.Increase in the need to outsource imaging in clinical trials
3.4.1.2.Rise in adoption of imaging in clinical trials
3.4.1.3.Advancements in the field of medical imaging technology

3.4.2.Restraint

3.4.2.1.Challenges related to integration of imaging in clinical trials

3.4.3.Opportunities

3.4.3.1.Imaging modality in development

3.4.4.Impact Analyses

3.5.COVID-19 Impact Analysis on Global Clinical trial imaging services market

CHAPTER 4:CLINICAL TRIAL IMAGING SERVICES MARKET, BY SERVICE TYPE

4.1.Overview

4.1.1.Market size and forecast

4.2.Clinical Trial Design & Consultation Services

4.2.1.Key market trends, growth factors and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis by country

4.3.Reading & Analytical Services

4.3.1.Key market trends, growth factors and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market analysis by country

4.4.Operational Imaging Services

4.4.1.Key market trends, growth factors and opportunities
4.4.2.Market size and forecast, by region
4.4.3.Market analysis by country

4.5.Project & Data Management Services

4.5.1.Key market trends, growth factors and opportunities
4.5.2.Market size and forecast, by region
4.5.3.Market analysis by country

4.6.Others

4.6.1.Key market trends, growth factors and opportunities
4.6.2.Market size and forecast, by region
4.6.3.Market analysis by country

CHAPTER 5:CLINICAL TRIAL IMAGING SERVICES MARKET, BY END USER

5.1.Overview

5.1.1.Market size and forecast

5.2.Pharmaceutical & Biotechnology Companies

5.2.1.Key market trends, growth factors and opportunities
5.2.2.Market size and forecast, by region
5.2.3.Market analysis by country

5.3.Medical Device Manufacturers

5.3.1.Key market trends, growth factors and opportunities
5.3.2.Market size and forecast, by region
5.3.3.Market analysis by country

5.4.Academic & Government Research Institutes

5.4.1.Key market trends, growth factors and opportunities
5.4.2.Market size and forecast, by region
5.4.3.Market analysis by country

CHAPTER 6:CLINICAL TRIAL IMAGING SERVICES MARKET, BY THERAPEUTIC AREAS

6.1.Overview

6.1.1.Market size and forecast

6.2.Oncology

6.2.1.Key market trends, growth factors and opportunities
6.2.2.Market size and forecast, by region
6.2.3.Market analysis by country

6.3.Neurology

6.3.1.Key market trends, growth factors and opportunities
6.3.2.Market size and forecast, by region
6.3.3.Market analysis by country

6.4.Endocrinology

6.4.1.Key market trends, growth factors and opportunities
6.4.2.Market size and forecast, by region
6.4.3.Market analysis by country

6.5.Cardiology

6.5.1.Key market trends, growth factors and opportunities
6.5.2.Market size and forecast, by region
6.5.3.Market analysis by country

6.6.Gastroenterology

6.6.1.Key market trends, growth factors and opportunities
6.6.2.Market size and forecast, by region
6.6.3.Market analysis by country

6.7.Others

6.7.1.Key market trends, growth factors and opportunities
6.7.2.Market size and forecast, by region
6.7.3.Market analysis by country

CHAPTER 7:CLINICAL TRIAL IMAGING SERVICES MARKET, BY REGION

7.1.Overview

7.1.1.Market size and forecast

7.2.North America

7.2.1.Key market trends and opportunities
7.2.2.Market analysis by country

7.2.2.1.U.S.

7.2.2.1.1.U.S. market size and forecast, by service type
7.2.2.1.2.U.S. market size and forecast, by end user
7.2.2.1.3.U.S. market size and forecast, by therapeutic area

7.2.2.2.Canada

7.2.2.2.1.Canada market size and forecast, by service type
7.2.2.2.2.Canada market size and forecast, by end user
7.2.2.2.3.Canada market size and forecast, by therapeutic area

7.2.2.3.Mexico

7.2.2.3.1.Mexico market size and forecast, by service type
7.2.2.3.2.Mexico market size and forecast, by end user
7.2.2.3.3.Mexico market size and forecast, by therapeutic area

7.2.3.North America market size and forecast, by service type
7.2.4.North America market size and forecast, by end user
7.2.5.North America market size and forecast, by therapeutic area

7.3.Europe

7.3.1.Key market trends and opportunities
7.3.2.Market analysis by country

7.3.2.1.Germany

7.3.2.1.1.Germany market size and forecast, by service type
7.3.2.1.2.Germany market size and forecast, by end user
7.3.2.1.3.Germany market size and forecast, by therapeutic area

7.3.2.2.France

7.3.2.2.1.France market size and forecast, by service type
7.3.2.2.2.France market size and forecast, by end user
7.3.2.2.3.France market size and forecast, by therapeutic area

7.3.2.3.UK

7.3.2.3.1.UK market size and forecast, by service type
7.3.2.3.2.UK market size and forecast, by end user
7.3.2.3.3.UK market size and forecast, by therapeutic area

7.3.2.4.Italy

7.3.2.4.1.Italy market size and forecast, by service type
7.3.2.4.2.Italy market size and forecast, by end user
7.3.2.4.3.Italy market size and forecast, by therapeutic area

7.3.2.5.Spain

7.3.2.5.1.Spain market size and forecast, by service type
7.3.2.5.2.Spain market size and forecast, by end user
7.3.2.5.3.Spain market size and forecast, by therapeutic area

7.3.2.6.Rest of Europe

7.3.2.6.1.Rest of Europe market size and forecast, by service type
7.3.2.6.2.Rest of Europe market size and forecast, by end user
7.3.2.6.3.Rest of Europe market size and forecast, by therapeutic area

7.3.3.Europe market size and forecast, by service type
7.3.4.Europe market size and forecast, by end user
7.3.5.Europe market size and forecast, by therapeutic area

7.4.Asia-Pacific

7.4.1.Key market trends and opportunities
7.4.2.Market analysis by country

7.4.2.1.Japan

7.4.2.1.1.Japan market size and forecast, by service type
7.4.2.1.2.Japan market size and forecast, by end user
7.4.2.1.3.Japan market size and forecast, by therapeutic area

7.4.2.2.China

7.4.2.2.1.China market size and forecast, by service type
7.4.2.2.2.China market size and forecast, by end user
7.4.2.2.3.China market size and forecast, by therapeutic area

7.4.2.3.Australia

7.4.2.3.1.Australia market size and forecast, by service type
7.4.2.3.2.Australia market size and forecast, by end user
7.4.2.3.3.Australia market size and forecast, by therapeutic area

7.4.2.4.India

7.4.2.4.1.India market size and forecast, by service type
7.4.2.4.2.India market size and forecast, by end user
7.4.2.4.3.India market size and forecast, by therapeutic area

7.4.2.5.South Korea

7.4.2.5.1.South Korea market size and forecast, by service type
7.4.2.5.2.South Korea market size and forecast, by end user
7.4.2.5.3.South Korea market size and forecast, by therapeutic area

7.4.2.6.Rest of Asia-Pacific

7.4.2.6.1.Rest of Asia-Pacific market size and forecast, by service type
7.4.2.6.2.Rest of Asia-Pacific market size and forecast, by end user
7.4.2.6.3.Rest of Asia-Pacific market size and forecast, by therapeutic area

7.4.3.Asia-Pacific market size and forecast, by service type
7.4.4.Asia-Pacific market size and forecast, by end user
7.4.5.Asia-Pacific market size and forecast, by therapeutic area

7.5.LAMEA

7.5.1.Key market trends and opportunities
7.5.2.Market analysis by country

7.5.2.1.Brazil

7.5.2.1.1.Brazil market size and forecast, by service type
7.5.2.1.2.Brazil market size and forecast, by end user
7.5.2.1.3.Brazil market size and forecast, by therapeutic area

7.5.2.2.Saudi Arabia

7.5.2.2.1.Saudi Arabia market size and forecast, by service type
7.5.2.2.2.Saudi Arabia market size and forecast, by end user
7.5.2.2.3.Saudi Arabia market size and forecast, by therapeutic area

7.5.2.3.South Africa

7.5.2.3.1.South Africa market size and forecast, by service type
7.5.2.3.2.South Africa market size and forecast, by end user
7.5.2.3.3.South Africa market size and forecast, by therapeutic area

7.5.2.4.Rest of LAMEA

7.5.2.4.1.Rest of LAMEA market size and forecast, by service type
7.5.2.4.2.Rest of LAMEA market size and forecast, by end user
7.5.2.4.3.Rest of LAMEA market size and forecast, by therapeutic area

7.5.3.LAMEA market size and forecast, by service type
7.5.4.LAMEA market size and forecast, by end user
7.5.5.LAMEA market size and forecast, by therapeutic area

CHAPTER 8:COMPANY PROFILES

8.1.BIOCLINICA INC.

8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Service portfolio
8.1.5.Key strategic moves and developments

8.2.BIOSPECTIVE INC.

8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Operating business segments
8.2.4.Service portfolio

8.3.CALYX

8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Service portfolio
8.3.5.Key strategic moves and developments

8.4.ERT CLINICAL

8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Operating business segments
8.4.4.Service portfolio
8.4.5.Key strategic moves and developments

8.5.ICON PLC.

8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Operating business segments
8.5.4.Service portfolio
8.5.5.Business performance.

8.6.IXICO PLC

8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Operating business segments
8.6.4.Service portfolio
8.6.5.Business performance

8.7.INTRINSIC IMAGING, LLC

8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Operating business segments
8.7.4.Service portfolio

8.8.IMAGING ENDPOINTS

8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segments
8.8.4.Service portfolio

8.9.MICRON, INC.

8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Operating business segments
8.9.4.Service portfolio
8.9.5.Key strategic moves and developments

8.10.MEDIAN TECHNOLOGIES

8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Operating business segments
8.10.4.Service portfolio
8.10.5.Business performance
8.10.6.Key strategic moves and developments

8.11.MEDPACE, INC.

8.11.1.Company overview
8.11.2.Company snapshot
8.11.3.Operating business segments
8.11.4.Service portfolio
8.11.5.Business performance
8.11.6.Key strategic moves and developments

8.12.PHARMTRACE

8.12.1.Company overview
8.12.2.Company snapshot
8.12.3.Operating business segments
8.12.4.Service portfolio

8.13.PROSCAN IMAGING

8.13.1.Company overview
8.13.2.Company snapshot
8.13.3.Operating business segments
8.13.4.Service portfolio